MAIA Biotechnology, Inc.
MAIA · Pharmaceutical Preparations · 60.8M shares · +61%/yr ↑ shares · EDGAR filings ↗
Reference price $1.39 · est. market cap ~$84M — last insider purchase, 2026-06-01 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D40Clinical/early-stage biotech — oncology clinical micro-cap, thin liquidity.
Strengths
- Liquidity — current ratio 1.7 (22nd)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Exec changeRecent 8-K item 5.02 8-K ↗
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Chronic dilutionShare count +61%/yr over 3y (dilution)
- Insider buyingInsider buying — 3 open-market buy(s) by 3 insider(s) (cluster of 3 insiders, ~$203,776, last 6mo) Form 4 ↗
- Notable holderHeld by 2 notable fund(s): STATE STREET CORP, FMR LLC (as of 2026-03-31)
- New fund positionNotable fund(s) opened this quarter: FMR LLC
Quarterly revenue
Last 2 quarters · from SEC filings.
Key metrics
Return on equity
-942.7%
Return on assets
-230.8%
Current ratio
1.7×
Tangible book value
$2M
Cash & investments
$0
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-01 | Gryaznov Sergei | Buy | 2.0K | $1.34 |
| 2026-06-01 | Vitoc Vlad | Buy | 73K | $1.39 |
| 2026-06-01 | Smith Stan | Buy | 75K | $1.34 |
| 2025-12-22 | CHAOUKI STEVEN M | Buy | 41K | $1.22 |
| 2025-12-22 | Smith Stan | Buy | 57K | $1.22 |
| 2025-12-22 | Louie Ngar Yee | Buy | 82K | $1.22 |
| 2025-12-05 | Smith Stan | Buy | 4.6K | $1.20 |
| 2025-12-05 | Smith Stan | Buy | 4.6K | $1.19 |
| 2025-12-05 | Smith Stan | Buy | 4.6K | $1.20 |
| 2025-11-28 | Vitoc Vlad | Buy | 50K | $1.14 |
| 2025-11-28 | Luput Cristian | Buy | 18K | $1.11 |
| 2025-11-28 | Vitoc Vlad | Buy | 50K | $1.14 |
| 2025-11-26 | Smith Stan | Buy | 15K | $1.04 |
| 2025-11-26 | Vitoc Vlad | Buy | 22K | $1.05 |
| 2025-11-26 | Vitoc Vlad | Buy | 22K | $1.05 |
| 2025-11-26 | Luput Cristian | Buy | 20K | $1.08 |
| 2025-11-25 | Vitoc Vlad | Buy | 10K | $0.97 |
| 2025-11-25 | Luput Cristian | Buy | 10K | $0.98 |
| 2025-11-25 | Vitoc Vlad | Buy | 10K | $0.97 |
| 2025-11-25 | Smith Stan | Buy | 15K | $0.98 |
| 2025-11-24 | Vitoc Vlad | Buy | 10K | $0.99 |
| 2025-11-24 | Smith Stan | Buy | 10K | $0.99 |
| 2025-11-21 | Vitoc Vlad | Buy | 1.8K | $0.92 |
| 2025-10-01 | Smith Stan | Buy | 19K | $1.30 |
| 2025-06-03 | Smith Stan | Buy | 33K | $1.50 |
| 2025-05-08 | Guerrero Ramiro | Buy | 20K | $1.50 |
| 2025-05-08 | Smith Stan | Buy | 67K | $1.50 |
| 2025-03-03 | Guerrero Ramiro | Buy | 33K | $1.50 |
| 2025-03-03 | Smith Stan | Buy | 25K | $1.50 |
| 2025-02-24 | Smith Stan | Buy | 50K | $1.50 |
| 2025-02-24 | Guerrero Ramiro | Buy | 73K | $1.50 |
| 2025-02-24 | Guerrero Ramiro | Buy | 73K | $1.50 |
| 2025-02-24 | Smith Stan | Buy | 50K | $1.50 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-05-22 | 2026-05-21 | 0001493152-26-024884 ↗ |
| 8-K | 2026-05-14 | 2026-05-14 | 0001493152-26-023168 ↗ |
| 10-Q | 2026-05-11 | 2026-03-31 | 0001493152-26-022154 ↗ |
| 8-K | 2026-04-16 | 2026-04-16 | 0001493152-26-016989 ↗ |
| 8-K | 2026-04-08 | 2026-04-08 | 0001493152-26-015662 ↗ |
| 8-K | 2026-04-02 | 2026-03-27 | 0001493152-26-014924 ↗ |
| 8-K | 2026-03-31 | 2026-03-31 | 0001493152-26-013879 ↗ |
| 8-K | 2026-03-27 | 2026-03-27 | 0001493152-26-013088 ↗ |
| 10-K | 2026-03-23 | 2025-12-31 | 0001493152-26-012088 ↗ |
| 8-K | 2026-03-04 | 2026-03-02 | 0001493152-26-008897 ↗ |
| 8-K | 2026-02-24 | 2026-02-24 | 0001493152-26-007831 ↗ |
| 8-K | 2026-01-20 | 2026-01-20 | 0001493152-26-002883 ↗ |